STING1 and neoplasm: Non-cell-autonomously, STING activation leads to the production of the type I interferons and other pro-inflammatory cytokines, which facilitate cross-talk between tumor cells and immune cells in the tumor microenvironment, enhancing antigen presentation and promoting robust antitumor immune response (59, 60).